Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis

Obstetrics and Gynecology

Volumn 109, Issue 5, 2007, Pages 1123-1128

  Giraldo, Paulo C ^b   Babula, Oksana ^b   Gonçalves, Ana Katherine S ^b   Linhares, Iara M ^b   Amaral, Rose Luce ^b   Ledger, William J ^b   Witkin, Steven S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; MANNOSE BINDING LECTIN 2;

ADULT; AGED; ALLERGY; ARTICLE; BRAZIL; CAUCASIAN; CODON; CONTROLLED STUDY; ENZYME DEGRADATION; ETHNIC DIFFERENCE; FEMALE; GENETIC CODE; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OUTPATIENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RECURRENT INFECTION; SEXUAL INTERCOURSE; VAGINA CANDIDIASIS; VAGINITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BRAZIL; CANDIDIASIS, VULVOVAGINAL; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VAGINOSIS, BACTERIAL;

EID: 34247591495     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000260386.17555.a5     Document Type: Article

References (23)

1. Giraldo P, von Nowaskonski A, Gomes FA, Linhares I, Neves NA, Witkin SS. Vaginal colonization by Candida in asymptomatic women with and without a history or recurrent vulvovaginal candidiasis. Obstet Gynecol 2000;95:413-6.
2. Witkin SS, Giraldo PC, Linhares I. New insights into the immune pathogenesis of recurrent vulvovaginal candidiasis. It J Gynecol Obstet 2000;12:114-8.
3. Fidel PL Jr. History and new insights into host defense against vaginal candidiasis. Trends Microbiol 2004;12:220-7.
4. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152:924-35.
5. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
6. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-9.
7. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003;37:1496-505.
8. Neth O, Jack DL, Dobbs AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000;68:688-93.
9. Ip WK, Lau YL. Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J Infect Dis 2004;190:632-40.
10. Pellis V, De Seta F, Crovella S, Bossi F, Bulla R, Guaschino S, et al. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin Exp Immunol 2005;139:120-6.
11. Lillegard JB, Sim RB, Thorkildson P, Gates MA, Kozel TR. Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J Infect Dis 2006;193:1589-97.
12. Babovic-Vuksanovic D, Snow K, Ten RM. Mannose-binding lectin (MBL) deficiency. Variant alleles in a Midwestern population of the United States. Ann Allergy Asthma Immunol 1999;82:134-43.
13. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003;37:733-7.
14. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physiochemical characteristics of human mannose binding protein expression by individuals of differing genotype. Immunology 1995;85:660-7.
15. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
16. Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immungenetics 1994;40:37-44.
17. Babula O, Danielsson I, Sjoberg I, Ledger WJ, Witkin SS. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004;191:762-6.
18. Witkin SS, Linhares I, Giraldo P, Jeremias J, Ledger WJ. Individual immunity and susceptibility to female genital tract infection. Am J Obstet Gynecol 2000;183:252-6.
19. Ledger WJ, Witkin SS. Are you a lumper or a splitter? Am J Obstet Gynecol 2006;195:1205-9.
20. Townsend R, Read RC, Turner MW, Klein NJ, Jack DL. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin Exp Immunol 2001;124:223-8.
21. Hamvas RM, Johnson M, Vlieger AM, Ling C, Sherriff A, Wade A, et al. Role for mannose binding lectin in the prevention of mycoplasma infection. Infect Immun 2005;73:5238-40.
22. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003;188:777-82.
23. Jensenius JC, Jensen PH, McGuire K, Larsen JL, Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003;31:763-7.